Burning around $4m a quarter, should get us to mid next year for a capital raise at a higher price. But only 2 trials disclosed, hopefully we have a new trial initiated ever quarter til H2 2025.
1. Phase 2 blood cancer trial
2. CMML German trial
3. iRBD Parkinson’s (more to come)
No mention of Scar treatment though, let’s hope we get an update on this in the next 2 months.
On track, but not bolting out the gates, so probably why we’re still so cheap.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report
SNT
syntara limited
Add to My Watchlist
3.92%
!
5.3¢

Burning around $4m a quarter, should get us to mid next year for...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $86.12M |
Open | High | Low | Value | Volume |
5.1¢ | 5.3¢ | 5.0¢ | $178.5K | 3.485M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26087 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 6328 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 374990 | 0.050 |
4 | 335097 | 0.049 |
2 | 221000 | 0.048 |
1 | 75000 | 0.047 |
1 | 200000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 6328 | 2 |
0.055 | 150000 | 1 |
0.057 | 483082 | 1 |
0.058 | 101600 | 2 |
0.059 | 595000 | 2 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online